Patents Examined by Christopher M. Gross
  • Patent number: 10006919
    Abstract: The present application provides arrays for use in immunosignaturing and quality control of such arrays. Also disclosed are peptide arrays and uses thereof for diagnostics, therapeutics and research.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 26, 2018
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Neal Woodbury, Stephen Johnston, Phillip Stafford
  • Patent number: 10001476
    Abstract: The invention, depending on aspect and embodiment, relates to capture probe controls, and capture and signal probe configurations and combinations of configurations that can facilitate accurate and efficient multiplex analyte detection, especially in electrochemical detection schemes.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: June 19, 2018
    Assignee: GenMark Diagnostics, Inc.
    Inventors: Michael Leonard Wood, Aviva Ruth Jacobs
  • Patent number: 10001489
    Abstract: An affinity ligand peptide library of IgG constructed on the basis of Protein A affinity model and the application of a design method thereof. According to the Molecular Mechanics—Poisson-Boltzmann surface area (MM/PBSA) method and on the basis of the known human IgG-Protein A complex structure, the hot spots of Protein A that have high affinity for human IgG are obtained analytically, and a Protein A simplified affinity model is built thereof. An affinity peptide library of IgG is constructed including heptapeptide and octapeptide structural modes. On the basis of the peptide structural modes, the types of inserted amino acids that ‘X’ residues represent are further identified using amino acid location method. Then, molecular docking and molecular dynamics simulation methods are used to screen the candidate peptides successively. Finally, the affinity peptide ligands that can effectively purify IgG are identified using affinity chromatography.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: June 19, 2018
    Assignee: TIANJIN UNIVERSITY
    Inventors: Yan Sun, Weiwei Zhao, Fufeng Liu, Qinghong Shi
  • Patent number: 9988623
    Abstract: Provided herein are methods for a novel bead-based next-generation “X-aptamer” selection scheme that extends aptamer technology to include X-modified bases, thus resulting in X-aptamers, at any position along the sequence because the aptamers are chemically synthesized via a split-pool scheme on individual beads. Also provides are application to a wide range of commonly used DNA modifications, including, but not limited to, monothioate and dithioate backbone substitutions. This new class of aptamer allows chemical modifications introduced to any of the bases in the aptamer sequence as well as the phosphate backbones and can be extended to other carbohydrate-based systems.
    Type: Grant
    Filed: October 10, 2013
    Date of Patent: June 5, 2018
    Assignees: AM Biotechnologies, LLC, Board of Regents of the University of Texas System
    Inventors: David G Gorenstein, Weiguo He, David E Volk, Miguel-Angel Elizondo-Riojas, Ross Durland, Johnnie Engelhardt
  • Patent number: 9983204
    Abstract: There is disclosed a microarray having base cleavable linkers and a process of making the microarray. The microarray has a solid surface with known locations, each having reactive hydroxyl groups. The density of the known locations is greater than approximately 100 locations per square centimeter. Optionally, oligomers are synthesized in situ onto the cleavable linkers and subsequently cleaved using a cleaving base. Optionally, the oligomers are cleaved and recovered as a pool of oligomers.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: May 29, 2018
    Assignee: CustomArray, Inc.
    Inventors: Karl Maurer, Dominic Suciu, Hetian Gao
  • Patent number: 9982253
    Abstract: A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof, exhibit enhanced thermal and chemical stability while presenting six modifiable loop domains which can be engineered to form a binding partner capable of binding to a target for applications in diagnostic and/or therapeutic compositions, methods and devices.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: May 29, 2018
    Assignee: Janssen Biotech, Inc.
    Inventor: Steven Jacobs
  • Patent number: 9982022
    Abstract: The present disclosure relates to a class of engineered polypeptides and provides a polypeptide comprising the sequence EX2X3X4AX6X7EIX10 X11LPNLX16X17X18QX20 X21AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55). The present disclosure also relates to populations of polypeptide variants based on a common scaffold, each polypeptide in the population comprising the amino acid sequence EX2X3X4AX6X7EIX10 X11LPNLX16X17X18QX20 X21AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55), and methods for selecting a desired polypeptide having an affinity for a predetermined target from said population.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: May 29, 2018
    Assignee: AFFIBODY AB
    Inventors: Erik Nordling, Joakim Nilsson, Patrik Strömberg
  • Patent number: 9968903
    Abstract: The invention features methods of making devices, or “platens”, having a high-density array of through-holes, as well as methods of cleaning and refurbishing the surfaces of the platens. The invention further features methods of making high-density arrays of chemical, biochemical, and biological compounds, having many advantages over conventional, lower-density arrays. The invention includes methods by which many physical, chemical or biological transformations can be implemented in serial or in parallel within each addressable through-hole of the devices. Additionally, the invention includes methods of analyzing the contents of the array, including assaying of physical properties of the samples.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: May 15, 2018
    Assignee: Life Technologies Corporation
    Inventors: Robert Hess, John Linton, Tanya S. Kanigan, Colin Brenan, Can Ozbal
  • Patent number: 9970928
    Abstract: Method of localizing a functional moiety (F) to at least one discrete area on a surface of a substrate, by propelling droplets of an aqueous dispersion of a synthetic construct of the structure F-S-L from a plurality of orifices located in a print head of an inkjet printer onto the surface. In the structure F-S-L, S is a spacer selected to provide a construct that is dispersible in water at a temperature of 25° C. in the absence of organic solvents or detergents, L is a diacyl- or dialkyl lipid and the at least one discrete area is in the shape of a symbol readable by optical character recognition (OCR) apparatus or a pattern having a combination of indicia in which the synthetic construct is present at different densities.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: May 15, 2018
    Inventors: Nicolai Vladimirovich Bovin, Stephen Micheal Henry, Stephen Robert Parker
  • Patent number: 9958437
    Abstract: The present application provides a method of quantifying an amount of a derivatized peptide displayed on a phage by phage display, the method comprising: providing a phage containing the target peptide thereon; reacting the phage containing the target peptide with a first reagent to derivatize the target peptide to form a derivatized peptide, reacting the derivatized peptide with a capture agent comprising a detection marker, thereby incorporating the detection marker within the derivatized peptide; and determining an amount of the detection marker, thereby quantifying the amount of the derivatized peptide displayed on the phage. A kit comprising a capture agent comprising a detection marker for quantifying the phage displayed derivatized peptides is also provided.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: May 1, 2018
    Assignee: The Governors of the University of Alberta
    Inventors: Ratmir Derda, Simon Ng, Seyed Mohammadreza Jafari
  • Patent number: 9944980
    Abstract: Methods of producing substrates having selected active chemical regions by employing elements of the substrates in assisting the localization of active chemical groups in desired regions of the substrate. The methods may include optical, chemical and/or mechanical processes for the deposition, removal, activation and/or deactivation of chemical groups in selected regions of the substrate to provide selective active regions of the substrate.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: April 17, 2018
    Assignee: Pacific Biosciences of California, Inc.
    Inventors: David R. Rank, Jonas Korlach, Yue Xu, Stephen Turner, Jeffery Wegener, Daniel Roitman, John Lyle
  • Patent number: 9938560
    Abstract: Provided herein are compositions and methods for identifying and detecting modulators of Ras protein conformational states through the use of second harmonic generation (SHG) technology. Also provided herein are methods for detecting a conformational changes in the three dimensional structure of a protein bound to a supported lipid bilayer.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: April 10, 2018
    Assignee: Biodesy, Inc.
    Inventors: Joshua S. Salafsky, Ryan P. McGuinness
  • Patent number: 9938312
    Abstract: The present invention provides chemical and chemo-enzymatic methods for the synthesis of a wide array of complex asymmetric multi-antennary glycans.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: April 10, 2018
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Geert-Jan Boons, Zhen Wang
  • Patent number: 9926194
    Abstract: A device and method detect cellular targets in a bodily source by utilizing a biofunctional pad comprised of a thin film of carbon nanotubes (CNT's). When antibodies are absorbed by the CNT's, cellular targets having markers matching the antibodies may be detected in a bodily source placed upon the biofunctional pad by measuring the conductivity of the thin film using conductive contacts electrically coupled to the thin film, as the binding of the receptors in the cellular targets to the antibodies changes the free energy in the thin film. In many respects, the device functions as a Field Effect Transistor (FET) with the bodily source, e.g., blood, acting as a polyelectrolyte liquid gate electrode to create a varying electrostatic charge or capacitance in the thin film based upon the binding of cellular targets in the source to the antibodies present on the biofunctional pad.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: March 27, 2018
    Assignee: University of Louisville Research Foundation, Inc.
    Inventor: Balaji Panchapakesan
  • Patent number: 9925509
    Abstract: The present invention relates to a method for combinatorial particle manipulation for producing high-density molecule arrays, and to the high-density molecule arrays obtained therefrom. In particular, the present invention relates to a method for producing high-density molecule arrays, in particular peptide or oligonucleotide arrays, by combinatorial patterning of particles, wherein the patterning is achieved by the selective and direct action of electromagnetic radiation.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: March 27, 2018
    Assignee: PEPperPRINTGmbH (DE/DE)
    Inventors: Frieder Märkle, Alexander Nesterov-Müller, Frank Breitling, Felix Löffler, Sebastian Schillo, Valentina Bykovskaya, Clemens Von Bojnicic-Kninski, Klaus Leibe
  • Patent number: 9926589
    Abstract: A complex mixture is analyzed for multiple nucleic acid sequences (e.g., DNA or RNA sequences) simultaneously by target specific multiplex amplification followed by single molecule detection of amplicons by Atomic Force Microscopy (AFM). The presence or absence of target nucleic acids can be determined from the presence or absence of specific amplicons for those nucleic acids. In addition, quantification of target nucleic acids in the complex mixture is achieved by determination of the numbers of amplicons.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: March 27, 2018
    Assignee: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Jason Reed, Andrey Mikheykin
  • Patent number: 9920367
    Abstract: The present invention provides methods and systems for analyzing mammalian transcriptomes, particularly, for low abundant transcripts, and with the use of high throughput technologies. Heptamer primers and sequence tags generated by the iterative randomized algorithm, as well as the sequencing-library generation system for amplifying and synthesis-based sequencing low abundant transcripts using the heptamer primers are also provided. The present invention further provides the use of the invention system and method for identifying key embryological lineage specific transcripts that anticipate differentiation of specific cell types.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: March 20, 2018
    Assignee: The Regents of the University of California
    Inventors: Vipul Bhargava, Pang Ko, Shankar Subramaniam
  • Patent number: 9920094
    Abstract: Affinity peptide ligands of mouse polyomavirus capsomers and a designed screening method thereof. The affinity peptide ligands can be used for separation and purification of the capsomers.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: March 20, 2018
    Assignee: TIANJIN UNIVERSITY
    Inventors: Lin Zhang, Xiaoyan Dong, Yanying Li, Xiaodan Liu, Yan Sun
  • Patent number: 9902994
    Abstract: The invention relates to a method of preparing a library of template polynucleotides with uniform sequence representation and to use of a library of templates prepared using this method for solid-phase nucleic acid amplification. In particular, the invention relates to a method of preparing a library of template polynucleotides which have common sequences at their 5? ends and at their 3? ends, which contains even representation of all the fragments present in a starting sample of nucleic acid before fragmentation. The invention is especially applicable to the preparation of short insert libraries, where the sample fragments are less than 150 base pairs in length.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: February 27, 2018
    Assignee: ILLUMINA CAMBRIDGE LIMITED
    Inventors: Niall Anthony Gormley, Melanie Anne Smith
  • Patent number: 9897611
    Abstract: Disclosed is a molecular library comprising a group of a plurality of molecules, wherein each member of the library is a polypeptide having a randomized sequence moiety and a microprotein moiety. The microprotein is a protein comprising an amino acid sequence of 30 or less amino acid residues having the ability to form a particular conformation by spontaneous folding in a solution and is, for example, chignolin comprising the amino acid sequence represented by SEQ ID NO: 1. Also, disclosed is a method for identifying a novel functional molecule using the library of the present invention.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: February 20, 2018
    Assignee: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Shinya Honda, Hideki Watanabe, Kazuhiko Yamasaki